# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Biotechnology company in Switzerland with the highest Free Cash Flow is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 16.61 B.
The Biotechnology company in Switzerland with the lowest Free Cash Flow is Evolva Holding SA (Swiss Stock Exchange: EVE.SW) at None.
The top 10 Biotechnology companies in Switzerland by Free Cash Flow are Roche Holding AG, Novartis AG, Tecan Group AG, Basilea Pharmaceutica AG, Sandoz Group AG, AC Immune SA, medmix AG, PolyPeptide Group AG, Kuros Biosciences AG and NLS Pharmaceutics AG.
The bottom 10 Biotechnology companies in Switzerland by Free Cash Flow are Evolva Holding SA, MoonLake Immunotherapeutics, BB Biotech AG, Idorsia Ltd, CRISPR Therapeutics AG, Lonza Group AG, Bachem Holding AG, ADC Therapeutics SA, Molecular Partners AG and Oculis Holding AG.